IV

Index Venture Growth Associates II Ltd

Long-term holder

Total reported value

—

Reporting period: 2020-09-30 · Number of holdings: 0

Index Venture Growth Associates II Ltd disclosed 0 holdings in its latest 13F filing for the period ending 2020-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
0
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
0
Sizing Uniformity
—

Recent moves

No holding changes this quarter

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1✓ Ikena Oncology INCStock-Other———

Holding changes this quarter

Position changes disclosed by Index Venture Growth Associates II Ltd for the quarter ending 2020-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Index Venture Growth Associates II Ltd and what type of investor is it?
Index Venture Growth Associates II Ltd is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2020-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 0 disclosed positions.
What are Index Venture Growth Associates II Ltd's largest equity positions?
Based on the latest 13F filing, Index Venture Growth Associates II Ltd's top holdings by market value are: 1. Ikena Oncology INC — $0.0
What changes did Index Venture Growth Associates II Ltd make in its most recent portfolio filing?
No notable portfolio changes were recorded for Index Venture Growth Associates II Ltd in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Index Venture Growth Associates II Ltd focus on?
Sector breakdown data is not yet available for Index Venture Growth Associates II Ltd. Check back after the next 13F processing cycle.